RxDoctor Payments Data

Keith Brantley, MD

Cardiovascular Disease · Zanesville, OHNPI 1609852672

Payments from drug & device makers

$3,186in general payments, 2019–2025

Across 182 payments — averaging $17.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$505
  • AstraZeneca$414
  • Boston Scientific$316
  • Pfizer$299
  • Novartis$245
  • Johnson & Johnson$165
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,07496%
  • Education$1124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,186 in reported general payments places this provider in the 60th percentile of 827 cardiovascular disease providers in Ohio.

See all cardiovascular disease providers in Ohio

Medicare billing

Part B allowed, 2024
$162,745
Medicare patients
1,185
Services billed
2,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban337$336,511
XareltoRivaroxaban239$219,388
Repatha SureclickEvolocumab110$84,914
EntrestoSacubitril/Valsartan49$45,235
FarxigaDapagliflozin Propanediol16$15,080
Repatha SyringeEvolocumab23$9,730
Potassium Chloride369$8,165
Nebivolol Hcl65$6,413
Metoprolol Succinate486$6,008
Torsemide271$4,985
Nifedipine ErNifedipine226$4,423
Isosorbide Mononitrate ErIsosorbide Mononitrate291$2,885
Diltiazem 24hr Er (Cd)Diltiazem Hcl99$2,459
Metoprolol Tartrate431$2,370
Losartan Potassium228$2,057

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$299$336,511337 claims
Johnson & JohnsonXarelto$165$219,388239 claims
NovartisEntresto$245$45,23549 claims
AstraZenecaFarxiga$414$15,08016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 827 cardiovascular disease providers in Ohio.

Other cardiovascular disease in Zanesville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →